Gene Query: NFE2L3

Dataset Description Geneva Score
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 97.69
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 83.87
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 72.31
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 66.91
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 53.22
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 52.68
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 50.78
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 50.39
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 48.61
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 48.49
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 48.12
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 44.65
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 44.63
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 44.52
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 44.52
RNA sequencing analysis of human embryonic stem cells and axial progenitors 44.08
Genetic-to-epigenetic Therapy for Pancreatic Cancer 43.92
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 43.56
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 43.56
RNA-seq analysis of RALD iPSCs after in vitro differentiation 42.38
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 41.67
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 41.57
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 41.21
Investigation about fibroblasts of different origins in culture 40.52
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 40.26
Crizotinib v. DMSO in SW480 cells 39.92
Effects of rFVIIIFc on human macrophages 37.59
RNA-seq of cells with TET1 knockout 37.5
Mechanistic Model-Guided Study of Embryonic Morphogenesis 36.21
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 35.57
Statins modulate endothelial transcriptional profile by inhibiting EZH2 35.4
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 33.91
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 33.91
Transcriptome analysis of virus infected tissues 33.75
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 33.25
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 33.25
SUV420H2 knockdown in PANC-1 33.14
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 32.66
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 32.1
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 31.4
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 31.36
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 31.13
Rorc disruption in human FG pancreatic cancer cells 30.99
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 30.88
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 30.61
Global expression profiles in cardiac progenitor cells generated by ISX-9 30.61
4sU-seq of HFF exposed to salt and heat stress 30.24
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 29.77
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 29.77
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 29.41
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 29.41
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 29.26
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 29.09
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 28.76
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 28.53
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 28.37
RNA-seq of human fibroblasts after irradiation 28.16
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 27.8
Recovery and analysis of nascent RNA 27.8
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 27.69
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 27.41
Lineage specific differentiation is influenced by state of human pluripotency 27.41
Characterization of parental and rociletinib-resistant derived H1975 cell lines 27.34
Transcriptome analysis of H9 hESC derived cerebral organoids 27.19
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 26.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 26.57
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 26.57
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 26.5
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 26.25
Gene expression analysis of immortalized human liver progenitor-like cells in culture 25.96
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 25.88
U1 snRNP telescripting regulates size-function stratified human genome 25.88
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 25.8
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 25.8
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 25.49
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 24.91
Cerebellar differentiation in Ataxia-Telangiectasia 24.88
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 24.79
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 24.7
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 24.42
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  24.1
Expression data from miR340 overexpressing human A549 cells 24.1
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 24.07
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 24.07
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 23.69
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 23.61
RNA-Seq from early time points in the kidney differentiation protocol 23.55
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 23.39
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 23.18
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 23.02
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 22.9
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 22.85
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 22.57
Altering cancer transcriptomes using epigenomic inhibitors 22.57
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 22.45
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 22.2
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 22.13
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 21.91
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 21.91
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 21.76
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 21.63
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 20.95
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 20.91
DIGIT regulates endoderm differentiation of human embryonic stem cells 20.73
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 20.72
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 20.69
MYCi361 regulates MYC target genes 20.67
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 20.65
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 20.64
RNA-seq of naive and primed ES cells (NHSM) 20.43
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 19.76
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 19.7
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 19.7
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 19.7
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 19.46
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 19.35
Effect of nuclear IL-33 on gene expression 19.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 19.22
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 19.17
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 18.97
RNA-seq of young and quiescent MRC-5 human fibroblasts 18.82
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 18.68
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 18.57
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 18.44
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 18.44
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 18.38
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 18.35
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 18.27
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 18.2
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 18.17
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 18.15
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 18.14
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 17.88
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 17.69
High-efficiency RNA-based reprogramming of human primary fibroblasts 17.45
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 17.39
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 17.39
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 17.36
Expression profiling of etoposide-induced senescent cells 17.29
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 17.2
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 17.16
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 16.99
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 16.98
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 16.98
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 16.98
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 16.98
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 16.98
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 16.94
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 16.94
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 16.94
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 16.8
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 16.76
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 16.76
Fbxo32 mediated gene expression program underlies EMT and metastasis 16.75
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 16.59
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 16.59
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 16.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 16.52
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 16.52
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 16.45
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 16.33
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 16.3
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 16.28
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 16.23
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 16.18
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 16.05
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 16.05
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 16.04
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 15.98
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 15.98
Silencing SPIB in attached and floating state of H1703 lung cancer cells 15.91
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 15.76
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 15.7
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 15.62
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 15.59
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 15.55
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 15.44
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 15.25
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 15.25
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 15.17
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 15.01
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 14.9
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 14.88
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 14.88
Gene expression profile of multiple myeloma cell lines treated with CB-5083 14.82
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 14.8
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 14.78
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 14.78
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 14.75
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 14.75
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 14.74
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 14.73
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 14.68
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 14.67
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 14.5
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 14.48
RNA seq comparison between scrambled and shGRP78 cells 14.46
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 14.36
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 14.36
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 14.34
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 14.28
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 14.28
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 14.24
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 14.23
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 14.01
Macrophage Ad5f35 M2 Challenge 13.93
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 13.92
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 13.92
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.75
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 13.72
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 13.69
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 13.69
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 13.68
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 13.67
Role of COP1 on MAP kinase transcriptional output in melanoma 13.53
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 13.5
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 13.5
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 13.5
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.49
Nrf2 regulated genes in A549 cells 13.39
Identification of Nrf2 regulated genes by RNA sequencing 13.39
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 13.38
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 13.16
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 13.03
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 13.03
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.97
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.97
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 12.96
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 12.91
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 12.88
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 12.75
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 12.71
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 12.71
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 12.68
Gene induction by the USP6 oncogene in response to interferon 12.52
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 12.38
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 12.37
Functional role of CPPED1 in trophoblasts. 12.36
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.35
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.35
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 12.28
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 12.28
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 12.25
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 12.24
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 12.13
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 11.99
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 11.94
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 11.93
Fusion discovery in breast cancer cell line 11.91
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 11.9
Depicting early human development and germ cell origin with porcine embryos 11.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 11.87
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 11.87
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 11.74
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 11.74
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 11.74
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 11.71
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 11.58
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 11.58
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 11.53
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 11.42
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 11.41
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 11.4
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 11.4
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 11.37
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 11.36
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 11.34
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 11.32
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 11.3
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 11.26
RNA-seq of tumor cells following angiopellosis extravasation 11.2
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 11.19
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 11.04
The effect of Abl kinases on non-small cell carcinoma global transcriptome 10.96
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 10.94
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 10.91
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 10.9
FOXD3 is a novel tumor suppressor in lung cancer 10.89
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 10.86
NRDE2 negatively regulates nuclear exosome functions 10.79
Morphological and molecular characterization of human dermal lymphatic collectors 10.72
MYCi975 regulates MYC target genes 10.71
AUF-1 affected genes in human skin cells 10.64
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 10.63
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.59
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 10.55
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 10.43
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 10.43
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 10.38
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 10.35
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 10.29
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 10.25
WRN knockout effects upon gene expression in SW48 and OVK18 10.22
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 10.19
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 10.18
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 10.17
BI Human Reference Epigenome Mapping Project 10.12
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 10.05
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 9.98
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 9.91
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 9.88
Identifying the molecular mode of action of itraconazole in colorectal cancer 9.87
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.86
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 9.83
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 9.72
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 9.62
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 9.59
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 9.59
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.57
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.57
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 9.56
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 9.43
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 9.4
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.39
Proliferation-correlated expression 9.39
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 9.38
Microprocessor mediates transcription termination in long noncoding microRNA genes 9.31
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 9.27
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.24
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 9.19
Examining serotonergic neuron differentiation from human iPSCs 9.18
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 9.17
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 9.14
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 9.09
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.03
Dynamic reorganization of nuclear architecture during human cardiogenesis 9.0
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 9.0
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.95
IRF2 is a master regulator of human keratinocyte stem cell fate 8.94
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.94
Regulation of hypoxia-inducible factor activity by ZMYND8 8.91
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 8.91
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 8.81
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 8.78
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.75
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 8.69
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 8.69
Macrophage Ad5f35 PhenoMap 8.59
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 8.54
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 8.41
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 8.41
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 8.37
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 8.37
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.32
RNA Seq of HMVEC under hypoxia 8.32
Epigenome regulation during epidermal lineage commitment [RNA-seq] 8.19
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 8.14
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 8.14
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 7.99
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 7.99
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 7.99
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.97
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 7.93
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 7.76
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.75
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 7.7
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 7.59
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 7.52
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.45
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.45
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.26
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 7.22
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.09
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.09
Targeted enhancer activation by a subunit of the integrator complex 7.03
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 6.93
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 6.89
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 6.78
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 6.78
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 6.58
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.49
Gene expression profile of human placenta from T. Cruzi infected mothers 6.39
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.38
RNA polymerase in pre-B-ALL cell lines 6.34
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.32
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.23
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 6.16
RNA-Seq in PWS iPSC-derived neurons 6.09
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 6.09
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.07
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.07
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 5.94
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 5.94
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 5.93
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.91
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.85
Transcriptomic profile of human embryonic renal corpuscles 5.82
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 5.8
TAF1 is critical for AE driven leukemogenesis 5.62
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.62
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 5.62
RNA sequencing analysis of selumetinib-resistant CRC cells lines 5.55
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 5.42
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 5.42
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 5.4
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 5.38
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.85
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.66
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 4.62
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.55
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 4.48
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 4.48
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.4
4.3
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 4.3
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.27
Transcriptome Profiling of Human Primary Monocytes 4.2
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.07
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 3.97
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.95
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.9
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.7
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.69
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.64
Total RNA-Seq data from leukemic patients with complex structural variants 3.64
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.64
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.64
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.61
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.59
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.55
LIN28A Over-expression RNAseq 3.49
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 3.39
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.33
Gene expression profiling in metabolically heterogeneous human lung tumors 3.25
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.22
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 3.2
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.18
RNA-seq of naive and primed ES cells 3.13
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.12
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.12
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.09
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 2.98
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.91
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.91
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.9
Transcriptome of EBV-infected gastric cancer cell lines 2.79
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.77
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.76
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.66
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.6
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 2.55
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 2.49
Transcriptome-wide response to synthetic chromatin protein PcTF 2.46
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.36
RNA sequencing of human pancreatic cancer cell lines 2.19
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.17
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.06
RNA seq analysis of human Fetal and adult derived Enterospheres 2.05
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.02
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.02
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.01
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.98
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.92
Molecular Criteria for Defining the Naive Human Pluripotent State 1.85
CSL RNA-Seq on HKC and SCC cell lines 1.84
CSL 1.84
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.83
Myc activation coordinates gene transcription and protein translation responses 1.66
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.6
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.55
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.5
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.5
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.5
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.4
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.4
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.37
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.36
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.36
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.32
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.3
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.17
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.11
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.1
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.0
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.89
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.88
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.8
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.7
Interphase condensins regulate ligand-depedent enhancer activation 0.7
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.68
Gene expression analysis of breast cancer cell-lines 0.68
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.65
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 0.64
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 0.64
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.63
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.57
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.49
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.49
Ribosome profiling upon inhibition of eIF4A 0.46
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.41
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.34
NAPRT activation of macrophages 0.33
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.32
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.3
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.29
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.19
Transcriptomic analysis of human macrophages in 3D 0.18
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.09
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation